168 related articles for article (PubMed ID: 36463958)
1. Linking nervous and immune systems in psychiatric illness: A meta-analysis of the kynurenine pathway.
Sales PMG; Schrage E; Coico R; Pato M
Brain Res; 2023 Feb; 1800():148190. PubMed ID: 36463958
[TBL] [Abstract][Full Text] [Related]
2. Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia.
Brum M; Nieberler M; Kehrwald C; Knopf K; Brunkhorst-Kanaan N; Etyemez S; Allers KA; Bittner RA; Slattery DA; McNeill RV; Reif A; Kittel-Schneider S
World J Biol Psychiatry; 2023; 24(7):564-577. PubMed ID: 36648064
[TBL] [Abstract][Full Text] [Related]
3. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies.
Marx W; McGuinness AJ; Rocks T; Ruusunen A; Cleminson J; Walker AJ; Gomes-da-Costa S; Lane M; Sanches M; Diaz AP; Tseng PT; Lin PY; Berk M; Clarke G; O'Neil A; Jacka F; Stubbs B; Carvalho AF; Quevedo J; Soares JC; Fernandes BS
Mol Psychiatry; 2021 Aug; 26(8):4158-4178. PubMed ID: 33230205
[TBL] [Abstract][Full Text] [Related]
4. The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis.
Almulla AF; Thipakorn Y; Vasupanrajit A; Tunvirachaisakul C; Oxenkrug G; Al-Hakeim HK; Maes M
Cells; 2022 Oct; 11(19):. PubMed ID: 36231075
[TBL] [Abstract][Full Text] [Related]
5. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis.
Hebbrecht K; Skorobogatov K; Giltay EJ; Coppens V; De Picker L; Morrens M
Front Immunol; 2021; 12():667179. PubMed ID: 34093561
[TBL] [Abstract][Full Text] [Related]
7. The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation.
Milaneschi Y; Allers KA; Beekman ATF; Giltay EJ; Keller S; Schoevers RA; Süssmuth SD; Niessen HG; Penninx BWJH
Brain Behav Immun; 2021 Oct; 97():167-175. PubMed ID: 34252568
[TBL] [Abstract][Full Text] [Related]
8. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways.
Anderson G; Jacob A; Bellivier F; Geoffroy PA
Curr Pharm Des; 2016; 22(8):987-1012. PubMed ID: 26654772
[TBL] [Abstract][Full Text] [Related]
9. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway and white matter microstructure in bipolar disorder.
Poletti S; Myint AM; Schüetze G; Bollettini I; Mazza E; Grillitsch D; Locatelli C; Schwarz M; Colombo C; Benedetti F
Eur Arch Psychiatry Clin Neurosci; 2018 Mar; 268(2):157-168. PubMed ID: 27619930
[TBL] [Abstract][Full Text] [Related]
11. Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder.
Cathomas F; Guetter K; Seifritz E; Klaus F; Kaiser S
Sci Rep; 2021 May; 11(1):9992. PubMed ID: 33976271
[TBL] [Abstract][Full Text] [Related]
12. The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites.
Bartoli F; Misiak B; Callovini T; Cavaleri D; Cioni RM; Crocamo C; Savitz JB; Carrà G
Mol Psychiatry; 2021 Jul; 26(7):3419-3429. PubMed ID: 33077852
[TBL] [Abstract][Full Text] [Related]
13. The kynurenine pathway in schizophrenia and bipolar disorder.
Erhardt S; Schwieler L; Imbeault S; Engberg G
Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499
[TBL] [Abstract][Full Text] [Related]
14. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
15. A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder.
van den Ameele S; van Nuijs AL; Lai FY; Schuermans J; Verkerk R; van Diermen L; Coppens V; Fransen E; de Boer P; Timmers M; Sabbe B; Morrens M
Bipolar Disord; 2020 Feb; 22(1):59-69. PubMed ID: 31398273
[TBL] [Abstract][Full Text] [Related]
16. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.
Arnone D; Saraykar S; Salem H; Teixeira AL; Dantzer R; Selvaraj S
Neurosci Biobehav Rev; 2018 Sep; 92():477-485. PubMed ID: 29940237
[TBL] [Abstract][Full Text] [Related]
17. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder.
Pu J; Liu Y; Zhang H; Tian L; Gui S; Yu Y; Chen X; Chen Y; Yang L; Ran Y; Zhong X; Xu S; Song X; Liu L; Zheng P; Wang H; Xie P
Mol Psychiatry; 2021 Aug; 26(8):4265-4276. PubMed ID: 31959849
[TBL] [Abstract][Full Text] [Related]
18. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
[TBL] [Abstract][Full Text] [Related]
19. Frontostriatal circuitry and the tryptophan kynurenine pathway in major psychiatric disorders.
Liang S; Zhao L; Ni P; Wang Q; Guo W; Xu Y; Cai J; Tao S; Li X; Deng W; Palaniyappan L; Li T
Psychopharmacology (Berl); 2024 Jan; 241(1):97-107. PubMed ID: 37735237
[TBL] [Abstract][Full Text] [Related]
20. The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis.
Almulla AF; Thipakorn Y; Vasupanrajit A; Abo Algon AA; Tunvirachaisakul C; Hashim Aljanabi AA; Oxenkrug G; Al-Hakeim HK; Maes M
Brain Behav Immun Health; 2022 Dec; 26():100537. PubMed ID: 36339964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
